Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2/Phase 3
NCT01666808
FACBC Outcomes for Post Prostatectomy
- NCT01666808 ↗
- Completed
- Emory University
- Standard
We haven't built an HCP commentary report on NCT01666808 (FACBC in Prostate Cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT01666808 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 12 | |
| YouTube | 1 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy
- Phase
- Phase 2/Phase 3
- Status
- Completed
- Conditions
- Prostate Cancer
- Interventions
- FACBC; Radiation therapy
- Arms
- FACBC PET scan · Experimental
- Conventional-Only Imaging · Active comparator
- Enrollment
- 165
- Primary outcomes
- Failure-free Survival
- Sponsor
- Emory University with National Cancer Institute (NCI)
- Start
- Sep 2012
- Primary completion
- Apr 18, 2022
- Results posted
- Yes
- Registry record
- NCT01666808 · updated Aug 2, 2023
Publications
linked from the registry- Jani AB, Schreibmann E, Goyal S, Halkar R, Hershatter B, Rossi PJ, Shelton JW, Patel PR, Xu KM, Goodman M, Master VA, Joshi SS, Kucuk O, Carthon BC, Bilen MA, Abiodun-Ojo OA, Akintayo AA, Dhere VR, Schuster DM. 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet. 2021 May 22;397(10288):1895-1904. doi: 10.1016/S0140-6736(21)00581-X. Epub 2021 May 7. PubMed 33971152
- Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Rossi PJ, Shelton JW, Patel PR, Jani AB. Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1003-1014. doi: 10.1016/j.ijrobp.2022.04.005. Epub 2022 Apr 11. PubMed 35417762